In ccRCC, melatonin has been shown to reduce metastasis by suppressing the Akt-MAPK cascade, NF-kB DNA-binding activity, and matrix metalloproteinase (MMP)-9 transactivation [304]. The gene discussed is AKT1; the disease is nonpapillary renal cell carcinoma.